Remote care technology and drug price limits garnered the most votes for having the biggest effect on the cost and delivery of U.S. healthcare.
The COVID-19 pandemic continues to scramble American healthcare, but it is already clear that telehealth and other forms of remote care are going to be lasting consequences.
That observation is reflected in results from our State of the Industry survey, which we revised this year to ask questions that look to the year ahead rather than assessing the year gone by. The survey had 100 respondents.
When we asked respondents to pick two technology developments that would have the biggest effect on the cost and development of healthcare in 2022, 66% picked remote care technologies, far outpacing the precision medicine, which was picked by 35% of the respondents, and at-home hospital care, which was picked by 29%.
We also asked about policy and political developments. It was closer race. Drug price limits (51%) and expansion of Medicare benefits (49%) finished neck and neck. Despite all the discussion, addressing social determinants of health (14%) and healthcare disparities (12%) ranked far lower.